Kent E. Lieginger
Director/Miembro de la Junta en University of the Sciences in Philadelphia .
Cargos activos de Kent E. Lieginger
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
University of the Sciences in Philadelphia | Director/Miembro de la Junta | 01/01/2013 | - |
Historial de carrera de Kent E. Lieginger
Antiguos cargos conocidos de Kent E. Lieginger.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2004 | 01/07/2014 |
The Genentech Foundation | Director/Miembro de la Junta | 01/01/2005 | 01/01/2012 |
University of California | Corporate Officer/Principal | - | - |
GSK PLC | Corporate Officer/Principal | - | - |
ACHAOGEN | Director/Miembro de la Junta | 13/03/2015 | - |
Independent Dir/Board Member | 13/03/2015 | - |
Estadísticas
Internacional
Estados Unidos | 6 |
Reino Unido | 2 |
Operativa
Corporate Officer/Principal | 3 |
Director/Board Member | 3 |
Independent Dir/Board Member | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 3 |
Miscellaneous | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
GSK PLC | Health Technology |
Empresas privadas | 3 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Achaogen, Inc.
Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
The Genentech Foundation | Miscellaneous |
- Bolsa de valores
- Insiders
- Kent E. Lieginger
- Experiencia